OPKO Health to Present at the Jefferies Virtual Healthcare Conference
OPKO Health (NASDAQ: OPK) will participate in the Jefferies Virtual Healthcare Conference from June 2-4, 2020.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
OPKO Health (NASDAQ: OPK) will participate in the Jefferies Virtual Healthcare Conference from June 2-4, 2020. Management is set to host one-on-one meetings with investors and will present on June 3 at 3:00 p.m. Eastern time. The presentation will be available via a live webcast and can be replayed afterward in the Investors section of OPKO's website.
OPKO is a biopharmaceutical and diagnostics company focused on leveraging its proprietary technologies to capture opportunities in rapidly growing markets. More information can be found at www.opko.com.
Details
News Market Reaction – OPK
The recorded move for OPK in the trading session of this news was -1.08%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MIAMI, May 27, 2020 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) announced today that management will be participating in the Jefferies Virtual Healthcare Conference being held June 2-4, 2020. Management will be hosting one-on-one meetings with investors via organized conference calls and will be presenting on Wednesday, June 3 at 3:00 p.m. Eastern time.
The presentation will be webcast live and available for replay in the Investors section of OPKO Health’s website and accessible by clicking here.
About OPKO Health, Inc.
OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.
Contacts:
LHA Investor Relations
Yvonne Briggs, 310-691-7100
ybriggs@lhai.com
or
Bruce Voss, 310-691-7100
bvoss@lhai.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.